https://www.marketscreener.com/quote/stock/NEKTAR-THERAPEUTICS-45013433/news/Nektar-Therapeutics-Presents-Data-for-Rezpegaldesleukin-in-Patients-with-Atopic-Dermatitis-and-Psori-41712751/?utm_source=telegram&utm_medium=social&utm_campaign=share